Henry J. Kaminski, MD

George Washington University

Henry J. Kaminski, MD serves as the Meta A. Neumann Professor and Chair of the Department of Neurology at the George Washington University School of Medicine and Health Sciences. He is an internationally recognized expert in the care of patients with myasthenia gravis and his laboratory focuses on the development of novel therapeutics for myasthenia gravis. His investigations have led to a targeting approach to enhance complement inhibition to the neuromuscular junction as a treatment for myasthenia gravis and he is moving the invention forward as CEO of ARC Biotechnology. He is the principal investigator for the National Institutes of Health-supported rare disease network, MGNet. In addition to serving as president of the AUPN, his previous leadership roles have been Chief of the Neurology Service at the Cleveland VA Medical Center and Chair of the Department of Neurology & Psychiatry at Saint Louis University. Over the course of his career, Dr. Kaminski has had many difficult conversations, but they have not become easier and never are the same.